Quick Answer
ROCKET PHARMACEUTICALS, INC. reported Total Assets of $330.45 million for fiscal year 2025.
ROCKET PHARMACEUTICALS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $330.45M | -37.4% |
| 2024 | $527.70M | -6.8% |
| 2023 | $566.34M | +2.6% |
| 2022 | $551.81M | +11.0% |
| 2021 | $497.02M | -15.9% |
| 2020 | $590.82M | +58.8% |
| 2019 | $372.12M | +48.1% |
| 2018 | $251.31M | +1147.4% |
| 2017 | $20.15M | -84.5% |
| 2016 | $129.65M | +14.4% |
| 2015 | $113.32M | +1952.9% |
| 2014 | $5.52M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $368.03M | -6.5% | -12.6% |
| June 30, 2025 | $420.98M | -5.7% | -10.6% |
| March 31, 2025 | $471.07M | -5.7% | -10.7% |
| December 31, 2024 | $527.70M | -6.8% | +34.0% |
| September 30, 2024 | $393.69M | -34.2% | -11.8% |
| June 30, 2024 | $446.41M | -3.3% | -10.6% |
| March 31, 2024 | $499.44M | -3.0% | -11.8% |
| December 31, 2023 | $566.34M | +2.6% | -5.4% |
- ROCKET PHARMACEUTICALS, INC. showed a decrease of -37.4% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, ROCKET PHARMACEUTICALS, INC.’s total assets has grown by 5886.4% (from $5.52 million to $330.45 million).
- The most recent figure is from ROCKET PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: